Aurora Cannabis Inc. (ACB) vs Emergent Biosolutions Inc. (EBS)
- Aurora Cannabis Inc. ACB 3.99 −2.68%
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
Aurora Cannabis Inc. and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $368.1M against $265.8M — 1.4× the size. Emergent Biosolutions Inc. grew revenue faster over the last twelve months: −9.56% against −18.2%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −38.1%) and the higher return on invested capital (−5.27% vs −5.58%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 12 and Aurora Cannabis Inc. on 7.
Valuation
Profitability
| Metric | ACB | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.74% | 55.87% | 53.94% |
| Operating margin | (12.13%) | (8.57%) | 0.00% |
| Net margin | (38.12%) | (22.96%) | 0.00% |
| Free cash flow margin | (17.19%) | 11.18% | 0.00% |
| Return on equity | (19.85%) | (40.29%) | (0.40%) |
| Return on assets | (15.19%) | (13.95%) | (3.32%) |
| Return on invested capital | (5.58%) | (5.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack